ISRCTN86750102 : CRASH2 Trial, a large randomised placebo-controlled trial among trauma patients with significant haemorrhage of the effects of an antifibrinolytic treatment on death and transfusion requirement
- Overall trial status
- Recruitment status
- No longer recruiting
Signs and Symptoms
...Editor in http://www.ncbi.nlm.nih.gov/pubmed/16790038 2. 2006 initial progress results in http://www.ncbi.nlm.nih.gov/pubmed/17072431 3. 2010 effects of...